| phosphodiesterase 3B |
FUROSEMIDE |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
FUROSEMIDE |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FUROSEMIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
FUROSEMIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
FUROSEMIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
FUROSEMIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
FUROSEMIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
FUROSEMIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
CLOMIPRAMINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
CLOMIPRAMINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
GALANTAMINE |
Muscarinic M5 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
BUTAMBEN |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
BUTAMBEN |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
GALANTAMINE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
GALANTAMINE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
BUTAMBEN |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
THEOPHYLLINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
THEOPHYLLINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, beta |
THIMEROSAL |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
THIOGUANINE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
THIOGUANINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
THIOGUANINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
BENZOIC ACID |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
BENZBROMARONE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
THIOGUANINE |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
THIMEROSAL |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
THIMEROSAL |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA1 (alpha 1) |
THIMEROSAL |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA2 |
THIMEROSAL |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 8 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
DICYCLOMINE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
DICYCLOMINE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, alpha |
BRIMONIDINE |
Chemokine CXCR1(IL-8A) |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
ERYTHROMYCIN |
Adrenergic alpha1D |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DICYCLOMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
BLEOMYCIN A2 |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
BLEOMYCIN A2 |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
BLEOMYCIN A2 |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 5a, mitochondrial |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 3 |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 2 |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 4 |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase XI |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase IX |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VIII |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VII |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase VA, mitochondrial |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase IV |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase III, muscle specific |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase I |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase XIV |
GOLD SODIUM THIOMALATE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
NEOMYCIN |
Insulin |
-20% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
NEOMYCIN |
Insulin |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
NEOMYCIN |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
NEOMYCIN |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
GOLD SODIUM THIOMALATE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
GOLD SODIUM THIOMALATE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
SULFABENZAMIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
SULFABENZAMIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 4 |
1-AMINOBENZOTRIAZOLE |
Muscarinic M4 |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
URETHANE |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
AMIODARONE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
WARFARIN |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor B2 |
WARFARIN |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| arginine vasopressin receptor 1A |
CHLOROXYLENOL |
Vasopressin V1A |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
CHLORPROMAZINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CHLORPROMAZINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
CHLORPROMAZINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
1-AMINOBENZOTRIAZOLE |
Phosphodiesterase PDE5 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
1-AMINOBENZOTRIAZOLE |
Phosphodiesterase PDE5 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
WARFARIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
WARFARIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
SULBACTAM |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
AMIODARONE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
AMIODARONE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
AMIODARONE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
TRETINOIN |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 2 |
6(5H)-PHENANTHRIDINONE |
Chemokine CCR2B |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
DEXAMETHASONE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
DEXAMETHASONE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
AMINOCAPROIC ACID |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
AMINOCAPROIC ACID |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
| cholecystokinin A receptor |
3-METHYLCHOLANTHRENE |
Cholecystokinin CCKA |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
RIFAMPIN |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
RIFAMPIN |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
BEZAFIBRATE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
BEZAFIBRATE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
RIFAMPIN |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
HYDROXYUREA |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
HYDROXYUREA |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 1 |
ETOPOSIDE |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic, beta-1-, receptor |
ETOPOSIDE |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 3 |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Adrenergic beta3 |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PACLITAXEL |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
PACLITAXEL |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
PACLITAXEL |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
PACLITAXEL |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
AMINOSALICYLIC ACID |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
AMINOSALICYLIC ACID |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
AMINOSALICYLIC ACID |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
PACLITAXEL |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
PACLITAXEL |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
PACLITAXEL |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
TIRILAZAD |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
RAPAMYCIN |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
RAPAMYCIN |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
RAPAMYCIN |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
ETHANOL |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
ETHANOL |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
CELECOXIB |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
CELECOXIB |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
CYCLOSPORIN A |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CYCLOSPORIN A |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
AMILORIDE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
RAPAMYCIN |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 2 |
CELECOXIB |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
ETHANOL |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
TIRILAZAD |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
INSULIN |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 4 |
INSULIN |
Muscarinic M4 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
RAPAMYCIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
RAPAMYCIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
TIRILAZAD |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
TIRILAZAD |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
CERIVASTATIN |
Dopamine D1 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4A, cAMP specific |
CEPHALEXIN |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
CEPHALEXIN |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4D |
CEPHALEXIN |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
CEPHALEXIN |
Phosphodiesterase PDE4 |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
CYCLOSPORIN A |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
INSULIN |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
ANISINDIONE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
AZTREONAM |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
BENAZEPRIL |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
MIFEPRISTONE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
ENALAPRIL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
ENALAPRIL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
ENALAPRIL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
ENALAPRIL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 2 |
DIETHYLSTILBESTROL |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
MIFEPRISTONE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor B2 |
MIFEPRISTONE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
ESTRONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ESTRONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
DIMETHYL SULFOXIDE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
DIMETHYL SULFOXIDE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
DIMETHYL SULFOXIDE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
DIMETHYL SULFOXIDE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
ENALAPRIL |
Serotonin 5-HT6 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
ETHINYLESTRADIOL |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
SIMVASTATIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
SIMVASTATIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
TERFENADINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor B2 |
TERFENADINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
THIORIDAZINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor B2 |
THIORIDAZINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
LEVAMISOLE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|